ClinicalTrials.gg
Not yet recruitingNCT07939048Updated Nov 16, 2026

Effect of Palm and LI4 (Hegu) Acupressure on Labor Pain, Labor Duration and Satisfaction

An interventional study of Palm Pressure with Wooden Comb and LI4 Acupressure with Electronic Acupuncture Pen and Meridian Massage Device in Labor Pain, Acupressure and Hand Point, sponsored by Emine Tekeli. Not yet recruiting. Open to female participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Emine Tekeli · Not applicable, Interventional, and Supportive care

How we know

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
105
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Female
01

Study summary

This randomized controlled trial aims to evaluate the effects of palm (hand point) pressure and LI4 (Hegu) acupressure applied during labor on labor pain, duration of labor, and maternal birth satisfaction. A total of 105 nulliparous women aged 18-35 years with a term, low-risk, singleton pregnancy in spontaneous labor will be randomly assigned to three groups of 35: a palm pressure group, an LI4 acupressure group, and a control group receiving routine labor care. In the palm group, women press a wooden comb into their own palm during contractions. In the LI4 group, the researcher applies pressure to the LI4 point during contractions using an Electronic Acupuncture Pen and Meridian Massage Device. Applications are performed during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm. Pain is measured with a Visual Analog Scale and an observer-rated pain expression scale (ESVADOPA) before and 30 minutes after each application. Duration of labor and neonatal Apgar scores are recorded, and birth satisfaction is assessed within 4 hours after birth. The study is conducted in a single center in Gaziantep, Türkiye.

02

Conditions studied

  • Labor Pain
  • Acupressure
  • Hand Point
  • LI4 Acupoint
  • Birth Satisfaction

Browse trials for

03

In context

Labor Pain

426 studies on the registry are indexed under Labor Pain; 76 are open to participants now.

This study's planned enrollment of 105 is close to the median of 100 across 349 interventional studies indexed under Labor Pain.

Browse Labor Pain studies →

Lead sponsor

This is the only study on the registry with Emine Tekeli as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18-35 years
  • Able to read, write and understand Turkish
  • Nulliparous woman with a term pregnancy (37-42 weeks of gestation)
  • Singleton, live fetus in vertex presentation
  • Spontaneous onset of labor
  • Cervical dilatation of 4 cm or more
  • Estimated fetal weight of 2500-4000 g confirmed by ultrasound by a physician
  • No risk factors in obstetric and medical history (low-risk pregnancy)
  • Willing to participate and gives written

Exclusion criteria

Exclusion Criteria:

  • Multiple pregnancy
  • Pregnancy achieved by in vitro fertilization (IVF)
  • Complicated pregnancy (e.g., gestational diabetes, hypertensive disorders)
  • Previous cesarean delivery
  • Presentation anomaly
  • Induction of labor
  • Neurological, psychiatric or communication-impairing disease
  • Use of, or planned use of, another pain-relief method (e.g., hot/cold application, TENS, aromatherapy, massage)
  • Structural or chromosomal fetal anomaly
  • Obesity according to the World Health Organization classification ( 30 kg/m2 or higher)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
105 participants (estimated)

Study arms

  • Experimental
    Palm Pressure Group

    Women apply pressure with a curved wooden comb to their own palm (Lao Gong point) during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm, under the supervision of the researcher. Routine labor care continues.

    Device: Palm Pressure with Wooden Comb

  • Experimental
    LI4 Acupressure Group

    The researcher locates the LI4 (Hegu) point with an Electronic Acupuncture Pen and Meridian Massage Device and applies pressure (about 3-5 kg of force) during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm. Routine labor care continues.

    Device: LI4 Acupressure with Electronic Acupuncture Pen and Meridian Massage Device

  • No intervention
    Control Group

    Women receive routine midwifery care in the delivery room with no additional intervention. Pain measurements are made at the same dilatation stages as in the other groups.

Interventions

  • DevicePalm Pressure with Wooden Comb

    Palm Pressure Group: A curved wooden comb is pressed by the woman into her own palm (Lao Gong point) during contractions. After the researcher demonstrates the technique, pressure is applied for six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm, with pauses during the rest phases between contractions.

    Also known as: Hand point comb, LI4 pressure

  • DeviceLI4 Acupressure with Electronic Acupuncture Pen and Meridian Massage Device

    The researcher locates the LI4 (Hegu) point on the back of the hand with an Electronic Acupuncture Pen and Meridian Massage Device, which signals the point by light and sound. Pressure (about 3-5 kg of force) is then applied with the device. The application is performed during six contractions (about 15-20 minutes) at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm, with pauses during the rest phases between contractions.

06

What researchers measure

Primary outcomes

  1. Labor pain intensity measured by Visual Analog Scale (VAS)

    Women rate the pain felt after a contraction on a vertical Visual Analog Scale from 0 (no pain) to 10 (severe pain). The mark is measured with a ruler and recorded as the pain score. Higher scores indicate more pain.

    Time frame: Before and 30 minutes after the application at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm during labor

Secondary outcomes

  1. Pain expression measured by the Rating Scale of Pain Expression during Childbirth (ESVADOPA)

    An independent observer who is unaware of group allocation rates pain expression during contractions with ESVADOPA. The scale has 6 items (facial muscles, body response, verbal response, restlessness, ability to relax, vegetative symptoms), each scored 0-3. Total scores range from 0 to 18; higher scores indicate more pain expression.

    Time frame: Before and 30 minutes after the application at cervical dilatations of 4-5 cm, 6-7 cm and 8-10 cm during labor

  2. Duration of labor

    Duration of labor stages calculated in minutes from times recorded on the labor follow-up form: admission to the delivery room, start and end of the second stage, and delivery of the placenta.

    Time frame: From admission to the delivery room until delivery of the placenta (during labor and birth)

  3. Birth satisfaction measured by the Birth Satisfaction Scale

    Women complete the 10-item Birth Satisfaction Scale (Turkish version), rated on a 5-point Likert scale (0-4), with reverse scoring for 4 items. Total scores range from 0 to 40; higher scores indicate greater birth satisfaction.

    Time frame: Within 4 hours after birth

  4. Neonatal Apgar score

    Apgar scores of the newborn, recorded on the labor follow-up form. Scores range from 0 to 10; higher scores indicate a better condition of the newborn.

    Time frame: 1 minute and 5 minutes after birth

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Ozgoli G, Sedigh Mobarakabadi S, Heshmat R, Alavi Majd H, Sheikhan Z. Effect of LI4 and BL32 acupressure on labor pain and delivery outcome in the first stage of labor in primiparous women: A randomized controlled trial. Complement Ther Med. 2016 Dec;29:175-180. doi: 10.1016/j.ctim.2016.10.009. Epub 2016 Oct 15. PubMed 27912944 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Feb 2027, 3 months later.

Of 192 non-industry interventional studies with no phase under Labor Pain, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 14. This study's planned 3 months is below that.

Counting every sponsor, half of 194 studies reached it within 9 months; a quarter within 5 and three quarters within 14.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2026
First posted
Nov 16, 2026
StartEst.
Nov 13, 2026
Primary completionEst.
Feb 28, 2027
CompletionEst.
Mar 30, 2027
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07939048
Lead sponsor
Emine Tekeli
Responsible party
Emine Tekeli (Research Assistant, University of Gaziantep) — Sponsor-investigator
First posted
Nov 16, 2026
Start date
Nov 13, 2026 (estimated)
Primary completion
Feb 28, 2027 (estimated)
Completion
Mar 30, 2027 (estimated)
Last update
Nov 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion